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Targeting neurotransmitter receptors with
nanoparticles in vivo allows single-molecule
tracking in acute brain slices
Juan A. Varela1,2, Julien P. Dupuis1,2, Laetitia Etchepare1,2, Agne`s Espana1,2, Laurent Cognet3,4 & Laurent Groc1,2
Single-molecule imaging has changed the way we understand many biological mechanisms,
particularly in neurobiology, by shedding light on intricate molecular events down to the
nanoscale. However, current single-molecule studies in neuroscience have been limited to
cultured neurons or organotypic slices, leaving as an open question the existence of fast
receptor diffusion in intact brain tissue. Here, for the ﬁrst time, we targeted dopamine
receptors in vivo with functionalized quantum dots and were able to perform single-molecule
tracking in acute rat brain slices. We propose a novel delocalized and non-inﬂammatory way
of delivering nanoparticles (NPs) in vivo to the brain, which allowed us to label and track
genetically engineered surface dopamine receptors in neocortical neurons, revealing inherent
behaviour and receptor activity regulations. We thus propose a NP-based platform for
single-molecule studies in the living brain, opening new avenues of research in physiological
and pathological animal models.
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T
he development of new nanoprobes and imaging techni-
ques has deeply impacted the neuroscience community
over the past few years. Functionalized nanoparticles (NPs)
have made possible the tracking of individual molecules in living
cells, drastically changing the way we understood synaptic
communication. In particular, neurotransmitter receptors have
been successfully labelled with functionalized quantum dots (QD)
and tracked diffusing along neurons, revealing new synaptic
regulation mechanisms. Thanks to single-molecule tracking
techniques, new properties of excitatory glutamate AMPA1–3
and NMDA4–6, inhibitory glycin7 and GABA8 receptors and
more recently the modulatory dopamine receptors9,10 have been
characterized opening up new targets for therapy. Undoubtedly,
single-molecule tracking imaging approaches shed new and
unexpected light on the molecular regulation of brain cell
communication11,12. This approach has the advantage to
identify the molecular behaviour of receptor sub-populations,
even minority ones, while retrieving molecule localizations with
sub-wavelength precision. In addition, the use of nanometre-sized
particles has even made possible to track target molecules within
conﬁned cellular compartments13,14. However, a clear limitation
of the single NP tracking approach has been the need to use
cultured neuronal systems, and not intact thick brain tissue.
Recently, single-molecule tracking in neurons using NPs has
been extended to cultured organotypic slices, which provide the
great advantage of an easy and direct access to superﬁcial cells15.
Although cultured neurons and organotypic slice cultures are
useful systems to investigate some neural mechanisms, they
unequivocally differ in many aspects from cell networks in intact
brain preparations. For instance, the architecture of the cellular
assemblies is strongly altered, causing changes in the extracellular
environment and intercellular communication. Extension of
single-molecule tracking techniques to thick acute brain slices
has thus been a major challenge that has bogged down our
understanding of nanoscale dynamic organization of
neurotransmitter receptors. Apart from technical difﬁculties
regarding the imaging of single nano-objects in high background
noise environments because of light scattering, absorption and
tissue auto-ﬂuorescence, targeting in vivo NP complexes into the
brain without strong activation of the immune defense has long
been an obstacle for single-particle tracking in tissue and drug
delivery. Currently, NPs are delivered to the brain either through
direct injection into the tissue or intravenous injection16–18.
However, the direct injection produces locally a high concentration
of NP that induces inﬂammation and activation of microglia,
leading to engulfed NP. The intravenous injection of NP limits the
brain delivery since only a tiny percentage is expected to cross the
blood–brain barrier and reach the nervous tissue.
Here, we explored an alternative strategy that consists of
injecting NP into the cerebrospinal ﬂuid knowing that the
choroid plexus epithelium is highly permeable. This delivery
strategy and optimized imaging microscopy allowed us to tackle
this imaging challenge and to track a surface neurotransmitter
receptor at the single NP level. We concentrated our efforts
on the dopamine receptor since the dopaminergic signalling in
the mammalian central nervous system contributes to major
functions including locomotion, novelty detection and long-term
memory formation19,20. As a consequence, dysregulations of
the dopaminergic system are associated with alterations in
synaptic function and plasticity as well as severe neurological
and psychiatric conditions such as Parkinson’s disease or
schizophrenia. Interestingly, new aspects of the dopamine
modulation of synaptic plasticity have been recently linked to
altered diffusion of surface dopamine receptors, unveiled by
ﬂuorescence recovery after photobleaching and single NP
tracking approaches10,21–23. Single-molecule tracking of
dopamine receptors in acute brain slices will offer new avenues
of research and potentially new therapeutical strategies.
Results
NP brain-tissue delivery without major inﬂammatory reaction.
We chose far-red emitting QD (with an emission maximum at
655 nm) to facilitate their detection deep in living brain slice,
taking advantage of the relatively low tissue auto-ﬂuorescence, light
absorption and scattering of tissues at these wavelengths. QD
functionalized with anti-rabbit F(ab’)2 fragments were conjugated
with polyclonal antibodies directed against GFP 1h before brain
injection. To deliver QD to the brain tissue via the cerebrospinal
ﬂuid, intra-ventricular injections of QD were performed in
newborn Sprague Dawley rats (1–4 days old). To compare the
impact of a local brain injection with an intra-ventricular injection,
we performed both types of injections in the same animal (one in
each hemisphere). Three hours after QD administration a massive
activation of microglia was observed in the injected tissue, as
shown by high CD11b staining and striking changes of microglia
morphology (Fig. 1a–c). Expectedly, those microglial cells
contained a high amount of internalized QD (Fig. 1a,b).
Consistently, almost no QD were observed outside microglia. In
contrast, the contralateral hemisphere (that is, ventricular
injection) shows microglia with classical non-activated state and
morphology, and most QD were scattered in the tissue without
speciﬁc co-localization with microglial cell markers. These data
indicate that ventricular injection of QD prevents microglial
activation observed after classical intra-tissue injection, allowing
the dispersion and diffusion of QD within the tissue of interest.
Brain distribution of untargeted QD after injection. To
characterize the distribution pattern of injected QD, rats were
killed 3 h after intra-ventricular injections and brains were
subsequently dissected for imaging. Fluorescence images were
recorded at video rate in the brain slices using a spinning
disk ﬂuorescence microscope, with three-dimensional (3D)
capabilities. Smaller ﬂuorescent nano-objects (ﬂuorescein
isothiocyanate-dextran), of average molecular weight of 4 kDa
(FD4) and 70 kDa (FD70) with estimated mean diameters of 3
and 15 nm, respectively24, were also injected into ventricles. From
sagittal brain slices, FD4 and FD70 had a stronger intensity close
to ventricles (Fig. 2a,b). The ﬂuorescence intensity decayed as the
dextran diffused into the brain tissue, with an expected larger
penetration depth for smaller dextran (Fig. 2b). Injected QD
(Fig. 2c) were detected with a similar diffusion pattern to the one
observed for FD70. At low magniﬁcation, QD appear to be
rapidly dispersed in the ventricular system, as also seen in the
sagittal brain slice (Fig. 2c). At high magniﬁcation, QD diffused
into the brain tissue hundreds of microns away from the main
ventricles (Fig. 2d). It should be mentioned that the brain
ventricular network is complex and ramiﬁed, precluding a strict
measurement of the distance travelled by QD away from
ventricular network. Finally, to conﬁrm that the detected QD
were not dragged out from the cerebrospinal ﬂuid during the slice
preparation procedure, 3D images were performed showing
evenly dispersed QD in the volume (Fig. 2e).
Detection of single QD in acute brain slices. Single QD display a
good photo-resistance allowing for long recordings (tens of
seconds) and displaying a characteristic blinking behaviour14,25.
We took advantage of these properties to reveal that single QD
could be detected in our brain-tissue preparations with the
spinning disk setup operating at a rate of 10–30 frames
per second (Fig. 3a–d). In particular, we checked that the
blinking behaviour of different QD identiﬁed in an imaging ﬁeld
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was not time-correlated ruling out the possibility that the
observed blinking was an out-of-focus imaging because of stage
vibrations (Fig. 3c). Importantly, single QD were detected in
acute slices at depths up to B50 mm inside the slice,
corresponding approximately to 3–4 pyramidal cell layers inside
the slice (Fig. 4a,b). The imaging depth capability was veriﬁed in
an independent assay, in which thinner acute slices (50-mm thick
slices prepared with a vibratome) were used to detect single QD
along the entire z axis of the slice (Supplementary Fig. 1). We also
performed a membrane permeability assay by adding propidium
iodide (PI) to the artiﬁcial cerebrospinal ﬂuid (ACSF) while
imaging brain slices. In 350-mm thick acute brain slices, 3D
reconstructed image shows that only the very ﬁrst layer contains
some stained nuclei while deeper layers are composed of
PI-negative healthy cells (Fig. 4c). Performing the same staining
in 50-mm thick slices demonstrate the presence of PI-positive
dead cells, scattered along the entire volume of the slice (Fig. 4c).
Thus, 350-mm thick acute brain slices were exclusively used and
experiments were performed at depth above 20mm within slices.
Characterization of QD-antibody complex. Cultured neurons
expressing CFP-dopamine D1R (CFP located at the extracellular
N-terminus of the receptor) and EGFP plasmids (to ﬁll
transfected neurons with a ﬂuorescent reporter) were incubated
with QD-antibody complexes at various ratio of QD and
antibodies. First, we veriﬁed that the use of polyclonal antibody
did not alter per se the diffusion of surface D1R, as suggested for
other surface receptors when used at higher concentrations26.
Comparing the surface dynamics of D1R targeted by either
monoclonal or polyclonal antibodies showed equal diffusion
coefﬁcient distributions (Supplementary Fig. 2a). It should also be
noted that we previously demonstrated that the bivalence of
antibody at this high dilution does not impact the receptor
trafﬁcking as compared with monovalent probes14. We then
tested the impact of various ratios of QD and antibody
concentrations on receptor dynamics. For this, QD-anti-GFP
complexes of different QD/antibody ratios (1:1, 1:10, 1:1,000)
were added to cultured neurons expressing D1-CFP and QD
trajectories were analysed. The comparison between conditions
shows that only a high concentration of anti-GFP (1:1,000) slows
down D1R surface dynamics, likely due to receptor crosslinking
(Supplementary Fig. 2b). On the basis of this knowledge, we then
used the 1:10 ratio in the rest of the study to perform our in vitro
and in vivo single QD tracking.
Single QD-D1 receptor detection in acute brain slices. In utero
electroporation was performed in pregnant Sprague Dawley rats at
day 16.5 of gestation, double-transfecting brain embryos with CFP-
D1R (CFP located at the extracellular N-terminus of the receptor)
and EGFP plasmids. Pups (1–4 days old) received an intra-cere-
broventricular injection of a QD/anti-GFP antibody complex that
recognizes the CFP motif of CFP-D1R (Fig. 5a)9,10. Three hours
after injection, pups were killed, sagittal brain slices were prepared
in ACSF and electroporated neurons were detected in the
neocortex, that is, both in the hippocampus and cortex
(for example, Fig. 5b). QD were detected throughout the
neocortex (for example, Supplementary Movie 1) and imaged
over 500 frames to retrieve individual QD trajectories. Strikingly,
numerous QD were found to rapidly diffuse along GFP-positive
dendrites (Fig. 5c, Supplementary Movie 2), therefore likely
speciﬁcally attached to surface D1R. Their motion type was
indeed different from those of single QD found to be stuck to the
membrane (immobile) or rapidly diffusing in the extracellular
space. However, since there is no easy way of washing away
ICVinj. Tissueinj.
ICV  or tissue
QD injection v
v
v
CD11b
QD655
DAPI
CD11b
QD655
DAPI
a
b c
Figure 1 | Comparison between intra-ventricular injection and local brain-tissue injection of QD. (a) Rats were injected with functionalized QD (shown
in red) inside a lateral ventricle in one hemisphere and directly in brain tissue in the opposite hemisphere. Pups were perfused with PFA 3 h after injection,
and coronal cuts were immunostained with CD11b antibodies (shown in green). Nuclei were stained with DAPI (shown in blue); scale bar, 200mm.
(b) Magniﬁed images of both hemispheres (from regions marked with red arrows) are shown below, corresponding to a region close to the lateral ventricle
(left) and a region close to the brain-tissue injection point (right), where activated microglia are detected with large amount of phagocyted QD (scale bars,
100mm). (c) The morphology of microglia with high concentration of engulfed QD changes dramatically due to cell activation (top: non-activated; bottom:
activated), also increasing the levels of CD11b expressed by microglia (scale bars, 10mm). ICV, intra-cerebroventricular.
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unbound QD inside living brains or slices (as achieved in cultured
neurons or organotypic slices) the ‘unbound’ fraction of anti-GFP-
QD were not further considered. QD trajectories diffusing along
GFP-positive neurons were analysed by calculating the mean
squared displacement (MSD) revealing that some QD movements
were conﬁned to spines (for example, Fig. 5di), whereas others
moved more freely onto the dendritic shaft (for example, Fig. 5dii).
Interestingly some active transport (for example, Fig. 5diii) was
also found but at very low frequency. Remarkably, we could
identify D1R-QD moving from dendrites to spine heads (for
example, Supplementary Movie 2), with the diffusion coefﬁcients
of QD in spines lower than those on dendrites (Fig. 5e).
To further test the speciﬁcity of QD targeting, we injected QD
functionalized with an anti-FLAG antibody instead of the
anti-GFP antibody that can bind to CFP-D1R. The imaging of
single QD/anti-FLAG complexes in electroporated brains
(EGFPþD1R-CFP) did not show trajectories diffusing along
GFP-positive neurons (Fig. 6, Supplementary Movie 3),
supporting the speciﬁcity of the trajectories observed using
anti-GFP functionalization. In another series of experiments, we
injected QD functionalized with an anti-GFP antibody into brains
electroporated only with EGFP (no D1R-CFP). Similarly, there
was no trajectory diffusing along GFP-positive (Fig. 6).
The diffusion coefﬁcient distributions of these conditions show
the marked difference between ‘speciﬁc’ and ‘unspeciﬁc’ staining
of D1R (Fig. 6). Altogether, the diversity of behaviours observed
by single NP tracking in brain slices strengthen the view that
neurotransmitter receptors, such as D1R, diffuse at the surface of
neurons in a compartment-dependent manner, and that the high
exchange rate between synaptic and extra-synaptic areas that was
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Figure 2 | Distribution map of injected Dextran and QD in rat brain. (a) Intra-ventricular injections of FD4 (top) and FD70 (bottom) allow diffusion of
dextran into the brain tissue (full-brain scale bars, 2mm, magniﬁed sections’ scale bars, 100mm). Smaller dextran (FD4) diffuses faster and further away
from the ventricles than larger dextran (FD70), as can be seen in the plotted intensity proﬁles (b) corresponding to the intensity detected across the
marked orange and red rectangles in the brain sections shown. (c) Intra-ventricular injections of QD show similar diffusion patterns to that of injected
ﬂuorescent dextran (particularly FD70). The image corresponds to a low magniﬁcation map of a 50mm thick sagittal cut of P1 rat brain, injected with QD
and killed and ﬁxed with PFA 3 h later (scale bar, 2mm). The map was composed stitching 120 images taken at  10 magniﬁcation in a spinning disk
confocal microscope (DAPI is shown in blue, QD shown in green). High-magniﬁcation image showing QD in the brain region marked with white line
(including part of cortex, ventricle and hippocampus) is shown in d. The high magniﬁcation map was composed stitching 90 images taken at  100
magniﬁcation in a spinning disk confocal microscope, subsequently thresholded and the pixels above threshold quantiﬁed, showing how QD diffuse into the
brain hundreds of microns away from the cerebrospinal ﬂuid ventricles. A section of this high-magniﬁcation image was studied in three dimensions
(e) showing that QD (green spots) are distributed across the slice volume (DAPI in grey) and the detected QD in the brain are not dispersed as an artefact
of the slicing procedure (scale bar, 10mm).
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revealed in cultured neurons, is now conﬁrmed in intact brain
tissue and is thus more than likely a key parameter of receptor
trafﬁcking and synaptic physiology.
Regulation of D1/5R surface dynamics in acute slice. In
cultured neuronal systems, the surface dopamine D1R are
highly regulated by the receptor activity status and associated
intracellular signalling10,21. We thus investigated the effect of the
dopamine D1R and D5R agonist SKF-38393 on D1R-QD
mobility in intact brain tissue. In cultured hippocampal
neurons, D1R diffusion coefﬁcient distribution was shifted
towards higher values after SKF-38393 (10min and 10 mM),
corresponding to a 55% increase in the median diffusion
coefﬁcient (Fig. 7a). Remarkably, we tracked surface D1R before
and after SKF-38393 exposure in acute slices and observed a 53%
increase in the diffusion coefﬁcient after activation (Fig. 7b). It is
important to note that QD complexes that did not co-localize
with GFP-positive neurons showed no signiﬁcant change in their
diffusion behaviour (Supplementary Fig. S3).
We then aimed at better characterizing the diffusion regulation
observed in the acute slice preparation. One must notice that
MSDs of individual neuronal membrane molecules display high
variability and are subject to statistical uncertainties due to the
limited length of the trajectories. This renders the comparison of
diffusion constants eventually blurred by the diverse types of
movements of individual receptors. We thus chose a previously
developed statistical approach to analyse globally the mobility
behaviours of sub-populations27, regardless of the trajectory
length. It consists in analysing the probability distributions of the
square displacements r2 (denominated ‘squared steps’) performed
by the molecules during a given time interval t pooling together
all trajectories. Different populations of mobile molecules were
identiﬁed at all t characterizing the evolution of squared steps for
increasing time interval t (Fig. 7c and Supplementary Fig. 4a,b).
Displaying the step distributions at different time intervals
(for example, 0.1 s and 0.95 s), it clearly appeared that
application of SKF-38393 affects the faster diffusing population
(large step portion of each distribution), whereas no effect
was observed for the slowly mobile population (Fig. 7c).
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Figure 3 | Single QD can be detected in ﬁxed brain slices. (a) Spinning disk confocal image from a hippocampal region of a 50mm thick rat brain slice
injected with QD (scale bar, 15 mm). The image corresponds to the average of 200 frames. (b) Time behaviour of four different QD (labelled as 1–4 in a),
showing that blinking is not synchronized and therefore, not an artefact due to stage vibrations. (c) Blinking behaviour of the ﬂuorescence of a single QD
(blue line), of an aggregate of QD (green line, shown with an arrow in a), and background ﬂuorescence (black line). (d) Examples of the ﬂuorescence
intensity of QD4 at times indicated with arrows in (c).
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Altogether, these data provide the ﬁrst direct evidence that the
activation of D1R in an intact brain slice speciﬁcally modulates
the receptor surface dynamics of the fast diffusing sub-
population, which have often been associated with recycling
and modulatory pool10,28.
Discussion
Since the initial discovery of the lateral diffusion of neurotrans-
mitter receptors using single-particle tracking7, the surface
diffusion of receptors and other membrane molecules has been
extensively studied in brain cell cultures, unravelling for instance
its key role in excitatory and inhibitory synapse adaptations3,5,29,30.
Semiconductor QD have been the preferred NP to label and track a
wide variety of biomolecules diffusing along the plasma
membrane3,25,31–33 of cultured glial cells34 and neurons2,25,29.
While photobleaching-based approaches were commonly used to
conﬁrm the global dynamic properties of surface receptors in brain
slices3,5, QD delivery issues currently limited the transfer of single-
particle tracking techniques to more integrated and preserved
preparations, limiting investigations of receptor diffusion in the
context of native tissue and fostering intense debate in the
neurobiological ﬁeld on the existence and relevance of surface
receptor dynamics in intact brain tissue. Recently, QD tracking of
surface lipids and receptors has been nicely extended to
organotypic brain slices since the preparation provides most of
the advantages of cultured systems15. Here, we report a technical
development that allows to track with high pointing accuracy the
dynamics of surface tagged-receptors in intact acute brain tissue,
demonstrating that dopamine receptor diffusion is ﬁnely regulated
upon receptor activation.
An efﬁcient method to deliver NP to the brain should beneﬁt a
variety of research lines in the ﬁelds of neurobiology and
medicine, such as the delivery of encapsulated drugs to the brain,
the use of NP to target and destroy tumours or the use of NP as
probes for single-molecule tracking in the brain. Brain injection
of NP has been used by others for drug delivery purposes35,36,
using local brain-tissue injections. The highly concentrated dose
of NP produced by stereotaxic injections presents an obvious risk
of inﬂammation, activating microglia that will engulf large
amounts of the injected nano-objects. An alternative to the
direct brain injection is to use the blood vascular system, but
injected objects can rarely cross a healthy blood–brain barrier.
We provide direct evidence of NPs delivered in vivo through the
brain ventricular system, with no sign of inﬂammation (activated
microglia) and equal dispersion of QD throughout the neocortex,
which constitutes a great advantage for single NP tracking. An
expected large proportion of injected QD were not co-localized
with transfected neurons, even after 1 to 2 h of washing the slices
in ACSF, suggesting that the acute slice has a different and more
compact extracellular architecture than the organotypic slice in
which the same type of QD can be rapidly ﬂushed in and out of
the preparation22. This is also in accordance to previous studies
that showed the reduction of targeting speciﬁcity of
functionalized NP because of the presence of biological media
adsorbed to its surface37. The QD-labelled D1R were found
moving along the transfected neurons in a similar way as in
cultured neurons9,10. The diffusion coefﬁcients of D1R in spines
were smaller than those moving along dendrites, an effect that is
likely the sum of two factors: (i) the stabilization of the receptors
in the spine head9,10 and/or (ii) the geometrical effect along the
spine neck due to tracking in a very thin tubular shape38. In
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addition, we unveiled that the activation of D1R by its agonist
SKF-38393 increased the receptor mobility in acute slice and
mobilized a sub-population of fast D1R that may resemble the
‘recycling’ ones28, a point to be tackled in future investigations.
Thus, single neurotransmitter receptor located at the surface of
neurons from acute brain slices can be tracked down in living
preparations, demonstrating the physiological importance of this
process in regulating the dynamic surface distribution and its
regulation by the receptor activity status.
It should be noted that our development is currently limited to
tagged-receptors since endogenous membrane receptor tracking
proved unsatisfactory. Indeed, we performed a series of experi-
ments in which we tracked down an endogenous glutamate
receptor (since there is currently no good antibody against
extracellular domains of D1R). In naı¨ve brains (no electropora-
tion), the diffusion coefﬁcient distributions from an anti-
endogenous receptor or anti-GFP antibodies were similar
(Supplementary Fig. 5). This indicates that endogenous and
‘unspeciﬁc’ antibody/QD complexes provide the same dynamics’
signature, precluding any strong conclusion. Furthermore, since
most neurotransmitter receptors are widely expressed across the
brain and since antibody/QD complexes need to be injected into
the lateral ventricle to avoid local inﬂammation, the penetration of
antibodies into the parenchyma will likely crosslink endogenous
receptors present at high concentration in the tissue. Thus, the
great advantage of anti-tag antibody to freely explore the
extracellular environment of the brain, until eventually binding
its target on transfected cells, will have to be transposed with
innovative engineered strategies to anti-endogenous receptor
antibodies.
To conclude, the successful strategy we described could
potentially be extended to in vivo imaging with the development
of new near-infrared nano-probes and imaging techniques,
pushing the limits of current high-resolution imaging setups and
single-molecule labels. Tracking tagged-receptors provides the
advantage to better understand the receptor trafﬁcking using
virtually all molecular strategies that modify proteins (for example,
mutation, domain deletion and chimaera). Speciﬁcally, this new
approach will improve our understanding of the mechanisms
governing dopamine receptor surface distribution, and shed
new lights on the pathological dysregulations affecting these
receptors in neuropsychiatric disorders39 and neurodegenerative
conditions40. Since strategies acting on the lateral mobility of D1R
and glutamate NMDA receptor in the striatum might improve
dyskinesia in L-DOPA-treated animal models of the Parkinson
disease22, one may envision the surface diffusion of
neurotransmitter receptors as a highly valuable therapeutic
target. Thus, assessing the mechanisms regulating receptor
diffusion and how they could be pathologically affected at the
nanoscale may help to provide new strategies to treat neurological
and psychiatric disorders.
Methods
Animals. Postnatal days 1–4 old Sprague Dawley rats (Janvier, France) were used
for this work, both male and female, treated according to the guidelines of the
University of Bordeaux/CNRS Animal Care and Use Committee.
Cell culture and transfection. Cultures of hippocampal neurons were
prepared from E18 Sprague Dawley. Brieﬂy, cells were plated at a density of
1.1 104 cells cm 2 on poly-lysine pre-coated coverslips. Cultures were kept at
37 C in 5% CO2 in a 3% horse serum containing neurobasal medium for the ﬁrst 3
days after dissection, after which the medium was changed for a serum-free
neurobasal medium (Invitrogen). Neurons were co-transfected at 7–10 days
in vitro with D1-CFP and EGFP using Effectene (QIAGEN) transfection kit. We
mixed 2 mg of DNA with 25 ml of Effectene and 8 ml of enhancer in 150ml of
reaction buffer, and then added the mixture to cultured neurons, which were
transferred to serum-free neurobasal medium 10min beforehand. After an
incubation period of 45min, neurons were placed in the old medium again.
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Figure 7 | Effect of SKF-38393 on D1R diffusion. (a) The effect of the D1
agonist SKF-38393 (10 mM for 10min) was tested in cultured neurons
(control, n¼ 1,205 trajectories; SKF-38393, n¼ 1,174 trajectories; Po0.001
Kolmogorov–Smirnov test, showing a shift in the diffusion coefﬁcient
distribution. (b) The effect was also compared pairwise in acute slices
based on QD that could be detected before and after treatment with
SKF-38393 (as illustrated in the snapshots, scale bar, 2 mm), showing a
signiﬁcant increase in diffusion (n¼ 24, control D¼0.04±0.01mm2 s 1,
SKF-38393 D¼0.07±0.02mm2 s 1, Wilcoxon matched-pairs signed rank
test P¼0.0099). (c) Step distribution analysis of acute slices was
performed for various lag times (example squared step distributions for lag
time t¼0.1 s and 0.95 s) for control and SKF-38393 conditions. The
squared step axes were normalized to 1 at the 0.5 cumulative distribution
point in order to make a direct visual comparison of the populations
(control, n¼ 28,404 steps; SKF-38393, n¼ 28,367 steps).
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In utero electroporation. E16.5 timed-pregnant Sprague Dawley rats were
anaesthetized with isoﬂuorane (induction 5% and surgery 2.5%). Animals were
kept over a heating blanket (homeothermic monitor Harvard apparatus) to
maintain their corporal body at 37 C, and surgery was done under the light of a
cold lamp (Olympus KL1500LCD). Abdominal wall was opened and the uterine
horns were carefully exposed and regularly moistened with NaCl 0.9% at 37 C.
DNA solution of pcDNA D1-CFP and pEGFP-N1 (0.5–1 mgml 1 for each plasmid
in PBS together with Bromophenol blue) was injected through the uterine wall into
one of the lateral ventricle of each embryo (4 ml) with a micropipette (capillaries
Harvard apparatus GC100-10 pulled with Nashirige pc-10 and cut to external
diameter of 20mm) linked to a Picospritzer III. Solution rapidly diffuses to the
non-injected lateral ventricle. Electroporation was made with forceps-type circular
electrodes, 10mm (platinum Tweezertrode BTX Harvard apparatus), positioned
horizontally in order to electroporate cortex and hippocampus. Five electrical
pulses (50V, 50ms duration and 1 s interval between pulses) were bilaterally
delivered with a generator (BTX Harvard apparatus ECM830). The uterine horns
were placed back in the abdominal cavity and 15ml of warm NaCl 0.9% were
added. Peritoneal wall and skin were sutured (Ethilon F2413 and Monocryl Y214
respectively) and Buprecare 0.06 mg g 1 with Marbocyl 0.016mg g 1 were
administered at the end of the surgery.
Immunostaining of CD11b. Comparison between intra-ventricular and
brain-tissue injections of QD were performed in living Sprague Dawley rat pups
(1–4 days old). Pups were injected 5 ml in one ventricle and 5 ml in the cortex of the
opposite hemisphere, along the same coronal line. Pups were strongly anaes-
thetized with Isoﬂurane 3 h after injection and perfused with NaCl 0.9% in water
and subsequently with 4% paraformaldehyde (PFA). Brains were then dissected
and left in 4% PFA for 24 h. Brains were then left in PBS for 48 h at 4 C. Coronal
slices 50 mm thick were cut in a Vibratome (Leica) and slices close to injection
points were recovered and washed thrice with PBS-Triton 0.3%. After incubation
with 2% normal donkey serum in PBS-Triton 1.5% to reduce unspeciﬁc back-
ground, slices were incubated with (1:200) mouse anti-rat integrin alphaM
[CD11b] monoclonal antibody (Millipore, #CBL1512Z) overnight at 4 C. Slices
were washed thrice with PBS-Triton 0.3% and ﬁnally incubated with secondary
antibody donkey anti mouse Alexa 568 (1:1,000) for 4 h at 4 C. Slices were ﬁnally
washed thrice with PBS and mounted in glass slices with VectashieldþDAPI
(Vector Labs). Images were obtained using an upright ﬂuorescence microscope and
the appropriate ﬁlters for each staining.
Single QD tracking in culture. Transfected cultures of hippocampal neurons were
mounted in a Ludin chamber (Life Imaging Services) and imaged with an inverted
ﬂuorescence microscope. QDs QD655 Goat F(ab’)2 anti-Rabbit IgG (Molecular
Probes, #Q-11421MP) were ﬁrst incubated for 30min with the GFP Rabbit Serum
Polyclonal Antibody (Molecular Probes, #A6455). Non-speciﬁc binding was blocked
by additional casein (Vector Laboratories, USA) to the QD 15min before use.
Neurons were ﬁrst incubated for 10min at 37 C in culture medium with pre-coated
QD (ﬁnal dilution 1:20,000 for anti-GFP coupled QD). Detection of the QD was
performed by using a mercury lamp and a ﬁlter cube optimized for Qdot 655
Nanocrystals (Semrock Bright-line QD655-C-000). Images were obtained with an
integration time of 50ms acquiring up to 1,000 consecutive frames. Signals were
detected using an EMCCD camera (Quantem, Roper Scientiﬁc). The effect of SKF-
38393 hydrochloride (Sigma-Aldrich, #D047) was tested by directly perfusing a 10mM
solution to the coverslip with either cultured neurons or acute slices for 10min.
To test whether the proportion of antibodies to QD in the study is adequate for
single receptor tracking, a titration of different concentration of antibodies was
performed by preparing the QD-anti-GFP complex before incubating with cells at
different QD-anti-GFP proportions. Dilutions of QD:anti-GFP ratios of
approximately 1:1, 1:10 and 1:1,000 were prepared in culture medium. QD655 Goat
F(ab’)2 anti-Rabbit IgG were incubated with GFP Rabbit Serum Polyclonal
Antibody at the desired ratio and were subsequently incubated with neuronal
cultures at DIV 8–10, keeping the QD dilution 1:20,000 in cell media in order to
have an equivalent QD number in the three different dilutions. Cells were
incubated with the complex for 3min, and three subsequent washes with medium
were performed to remove QD excess. Imaging was performed as described above.
QD-antibody complexes for in vivo labelling of D1 receptors. Following
titration experiment results, all experiments in slices were performed at a dilution of
approximately 1 QD to 10 anti-GFP. QD-antibody complexes were prepared by
incubating 3ml of QD655 Goat F(ab’)2 anti-Rabbit IgG (Molecular Probes,
#Q-11421MP) with either 3ml of GFP Rabbit Serum Polyclonal Antibody (Molecular
Probes, #A6455) or 3ml of FLAG Monoclonal Antibody (Sigma-Aldrich, #2555).
The cocktail was then diluted in 54ml of PBS (ﬁnal QD concentration of 50 nM),
vortexed, brieﬂy spun down and incubated for 30min at room temperature.
Intra-ventricular injections. Injections of QD were performed in living Sprague
Dawley rat pups (1–4 days old), injecting 5 ml of QD dispersion in each hemisphere
at a concentration of 50 nM. Under cold light illumination, the injection place was
found by ﬁrstly drawing a virtual line between the eye and lambda (easily seen
through the skin), secondly ﬁnding the midpoint of that line, and thirdly moving
2mm caudal from that midpoint along the virtual line. The injection was
performed in that point, at a depth of 2.6mm for P1 pups, 2.9mm for P2 pups,
3.1mm for P3 pups and 3.5mm for P4 pups. Injected pups were left back with
their mother for 3 h, after which they were killed and brains were dissected. The
same procedure was applied for the injection of ﬂuorescently labelled dextrans
(Sigma-Aldrich), diluted 1:5 in PBS.
Acute brain slices preparation. Postnatal day (P) 1–4 Sprague Dawley rats were
anaesthetized with isoﬂurane and parasagittal brain slices (350 mm thick) were
prepared in an ice-cold sucrose buffer solution containing (in mM): 250 sucrose, 2
KCl, 7 MgCl2, 0.5 CaCl2, 1.15 NaH2PO4, 11 glucose and 26 NaHCO3 (gassed with
95% O2/5% CO2). Slices were then incubated for 30min at 33 C and subsequently
stored at room temperature in an ACSF solution containing (in mM): 126 NaCl,
3.5 KCl, 2 CaCl2, 1.3 MgCl2, 1.2 NaH2PO4, 25 NaHCO3 and 12.1 glucose
(gassed with 95% O2/5% CO2; pH 7.35). Slices were used for imaging, 1–4 h after
preparation.
Spinning disk microscopy. QD imaging in acute slices was performed in a Leica
DMI6000 inverted microscope (Leica Microsystems) with a Yokogawa spinning disk
unit CSU-X1. The setup was equipped with live cell chamber and temperature was
constantly kept at 37 C. Tissue scans were obtained stitching multiple ﬁelds of view
with either  10 air,  63 oil and  100 oil objectives, with exposure times of
50–100ms per frame. DAPI staining in ﬁxed tissue was excited with a 405 nm laser
line, and detected through a standard DAPI emission ﬁlter. EGFP transfections were
excited with a 491 nm laser line and emission was observed with a standard GFP
ﬁlter. For single-QD tracking, QD were excited with a 561 nm diode laser line set at
200mW, yielding 1.29mW at the  63 objective exit, and the emission was ﬁltered
with a 650–800 nm band-pass ﬁlter. QD tracking images were obtained with  63 oil
objective (Leica HCX PL APO 63 /1.40-060) and integration times of 20–50ms
acquiring at least 500 consecutive frames for each imaged region. Images were
acquired using an Evolve EM-CCD camera (Photometrics), setting the EM gain at
600. The z stacks were done with a galvanometric stage (Leica Microsystems) and
mosaics were done with a motorized stage Scan IM (Ma¨rzha¨user). The system was
controlled by MetaMorph software (Molecular Devices).
Particle tracking. Images were processed with PalmTracer module in Metamorph
software (Molecular Devices). The two-dimensional trajectories of single molecules
in the plane of focus were constructed by correlation analysis between consecutive
images using a Vogel algorithm. The instantaneous diffusion coefﬁcient (D) of QD
was calculated for each trajectory, from linear ﬁts of the ﬁrst four points of the
MSD versus time function MSD(t)¼ 4Dt. The pointing accuracy of our system was
determined at B30 nm.
Statistical analysis. Comparisons between groups for instantaneous diffusion
coefﬁcients were performed using Kolmogorov–Smirnov test (distribution com-
parison), Wilcoxon matched-pairs signed rank test. Signiﬁcance levels were deﬁned
as **Po0.01.
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